Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Douglas W. Hobbs is active.

Publication


Featured researches published by Douglas W. Hobbs.


Archive | 2002

Aryl and biaryl piperidines used as mch antagonists

Douglas W. Hobbs; Tao Guo; Rachael C. Hunter; Huizhong Gu; Suresh Babu; Yuefei Shao


Archive | 2004

Cyclic amine bace-1 inhibitors having a benzamide substituent

Jared N. Cumming; Ulrich Iserloh; Andrew W. Stamford; Corey Strickland; Johannes H. Voigt; Yusheng Wu; Ying Huang; Yan Xia; Samuel Chackalamannil; Tao Guo; Douglas W. Hobbs; Thuy X. H. Le; Jeffrey F. Lowrie; Kurt W. Saionz; Suresh D. Babu


Archive | 2007

Heterocyclic substituted pyridine compounds with cxcr3 antagonist activity

Stuart B. Rosenblum; Joseph A. Kozlowski; Neng-Yang Shih; Brian F. Mcguinness; Douglas W. Hobbs


Archive | 2009

METHOD OF TREATING CXCR3 MEDIATED DISEASES USING HETEROCYCLIC SUBSTITUTED PIPERAZINES

Jay S. Fine; Seong Heon Kim; Gopinadhan N. Anilkumar; Michael K. C. Wong; Qingbei Zeng; Stuart B. Rosenblum; Joseph A. Kozlowski; Yuefei Shao; Brian F. Mcguinness; Douglas W. Hobbs


Archive | 2003

Pyrazolopyrimidines suitable for the treatment of cancer diseases

Timothy J. Guzi; Kamil Paruch; Michael P. Dwyer; Ronald J. Doll; Viyyoor Moopil Girijavallabhan; Alan Mallams; Carmen Alvarez; Kartik M. Keertikar; Jocelyn Rivera; Tin-yau Chan; Vincent Madison; Thierry O. Fischmann; Lawrence W. Dillard; Vinh D. Tran; Zhen Min He; Ray Anthony James; Haengsoon Park; Vidyadhar M. Paradkar; Douglas W. Hobbs


Archive | 2010

Zur Behandlung von Krebserkrankungen geeignete Pyrazolopyrimidine

Timothy J. Guzi; Kamil Paruch; Michael P. Dwyer; Ronald J. Doll; Viyyoor M. Girijavallabhan; Alan K. Mallams; Carmen Alvarez; Kartik M. Keertikar; Jocelyn Rivera; Tin-Yau Chan; Vincent S. Madison; Thierry O. Fischmann; Lawrence W. Dillard; Vinh D. Tran; Zhen Min He; Ray Anthony James; Haengsoon Park; Vidyadhar M. Paradkar; Douglas W. Hobbs


Archive | 2010

Pyrazolopyrimidine derivative as cyclin dependent kinase inhibitor

Carmen Alvarez; Tin-Yau Chan; Lawrence W. Dillard; Ronald J. Doll; Michael P. Dwyer; Thierry O. Fischmann; Viyyoor M. Girijavallabhan; Timothy J. Guzi; Zhen Min He; Douglas W. Hobbs; Ray Anthony James; Kartik M. Keertikar; Vincent S. Madison; Alan K. Mallams; Vidyadhar M. Paradkar; Haengsoon Park; Kamil Paruch; Jocelyn Rivera; Vinh D. Tran; マラムス アラン; パルチ カミル; エム. キールティカール カルティック; エス. アルバレス カルメン; リベラ ジョセリン; ウォルシュ ホッブス ダグラス; ミン ホー チェン; ティン−ヤウ チャン; オー. フィッシュマン ティエリー; ジェイ. グジ ティモシー; エム. パラドカル ビドヤドハー


Archive | 2009

Aryl piperidine and biaryl piperidine, used as mch antagonist

Suresh Babu; Huizhong Gu; Tao Guo; Douglas W. Hobbs; Rachael C. Hunter; Yuefei Shao; ディー. バブ スレス; グオ タオ; ダブリュー. ホッブス ダグラス; グ フイツォング; シャオ ユエフェイ; シー. ハンター ラッセル


Archive | 2008

Nouveaux pyrazolopyrimidines utilisés comme inhibiteurs des kinases dépendants des cyclines

Timothy J. Guzi; Kamil Paruch; Michael P. Dwyer; Ronald J. Doll; Viyyoor M. Girijavallabhan; Alan K. Mallams; Carmen Alvarez; Kartik M. Keertikar; Jocelyn Rivera; Tin-Yau Chan; Vincent S. Madison; Thierry O. Fischmann; Paul Kirschmeier; Rajat Bannerji; Lawrence W. Dillard; Vinh D. Tran; Zhenmin He; Ray Anthony James; Haengsoon Park; Vidyadhar M. Paradkar; Douglas W. Hobbs


Archive | 2007

Composés de pipérazine substitués hétérocycliques présentant une activité antagoniste de cxcr3

Stuart B. Rosenblum; Joseph A. Kozlowski; Neng-Yang Shih; Brian F. Mcguiness; Douglas W. Hobbs

Collaboration


Dive into the Douglas W. Hobbs's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tao Guo

Princeton University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge